A Systematic Review of Flurbiprofen 8.75 mg Dose and Risk of Haemorrhagic Events.

Dhanda, Sandeep; Evans, Alison; Roy, Debabrata; Osborne, Vicki; Townsley, Adam; Coutinho, Graça; Kulasekaran, Anuradha; Shakir, Saad

A Systematic Review of Flurbiprofen 8.75 mg Dose and Risk of Haemorrhagic Events.

Dhanda, Sandeep; Evans, Alison; Roy, Debabrata; Osborne, Vicki; Townsley, Adam; Coutinho, Graça; Kulasekaran, Anuradha; Shakir, Saad.

Afiliação

Dhanda S; Drug Safety Research Unit, Southampton, United Kingdom.
Evans A; University of Portsmouth, Portsmouth, United Kingdom.
Roy D; Drug Safety Research Unit, Southampton, United Kingdom.
Osborne V; University of Portsmouth, Portsmouth, United Kingdom.
Townsley A; Drug Safety Research Unit, Southampton, United Kingdom.
Coutinho G; University of Portsmouth, Portsmouth, United Kingdom.
Kulasekaran A; Drug Safety Research Unit, Southampton, United Kingdom.
Shakir S; University of Portsmouth, Portsmouth, United Kingdom.

Front Pharmacol ; 12: 726141, 2021.

Article em En | MEDLINE | ID: mdl-34421619

Palavras-chave

bleeding; flurbiprofen; haemorrhage; lozenge; oromucosal spray

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies / Systematic_reviews Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google